UPDATE: Syros Pharma To Receive $10M Upfront Payment From Incyte And $10M Equity Investment At Premium To Current Market Price, Could Receive Up To $47M In Target Validation & Other Fees, And Another $115M In Milestone Payments
Hal Lindon